Dipeptidyl peptidase4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: a nationwide populationbased cohort study
Arch Gerontol Geriatr 46:181190 Malaguarnera M, Vacante M, Bertino G, Neri S, Malaguarnera M, Gargante MP, Motta M, Lupo L, Chisari G, Bruno CM, Pennisi G, Bella R (2011) The supplementation of acetyl-l-carnitine decreases fatigue and increases quality of life in patients with hepatitis c treated with pegylated interferon-alpha 2B plus ribavirin
By Application: T2DM dominates, Obesity growing fastest Type 2 Diabetes Mellitus maintained the dominant application position in the GLP-1 Receptor Agonist Market in 2025, driven by the large established prescriber base, comprehensive insurance coverage for diabetes indications, and the longer clinical history of GLP-1 therapy in diabetes management that has built physician comfort and treatment guideline endorsement
These hormones signal fullness to the brain, slow down digestion, and improve how the body uses insulin
